top of page
Supported projects
SPIREA
UK-based biotech developing its proprietary ELIVATE linker technology, significantly expanding the range of therapeutic payloads that can be used in antibody-drug conjugates (ADCs).
PSCC's entrance
June 2026
Localization
UK - Cambrigde
Modality
ADC
Development status
Biotech - Lead optimization
Award(s)
bottom of page